Last updated 2 months ago
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
540 patients around the world
Available in Argentina, Puerto Rico, Mexico, United States, Spain
Gilead Sciences
22Research sites
540Patients around the world
This study is for people with
Breast Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Recruiting
Hospital Británico de Buenos Aires - CABA
Recruiting
Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja
Recruiting
Centro Médico Caipo (centro para la atención integral de pacientes oncológicos)
Recruiting
Instituto de Oncología Ángel H. Roffo - CABA, Buenos Aires
Recruiting
Instituto de Oncología de Rosario - IOR
Recruiting
FAICIC Clinical Research
Recruiting
Oncológico Potosino
Recruiting
iBiomed Investigación Biomédica Guadalajara
Recruiting
Panamerican Clinical Research S.A. de C.V
Recruiting
StudyASCENT-03
SponsorGilead Sciences
Study typeInterventional
Conditions
Breast Cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05382299
